Novartis Pharmaceuticals Corporation v. Lupin Inc. et al
Novartis Pharmaceuticals Corporation |
Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings, S.A., Lupin Limited and Lupin Inc. |
1:2024cv01045 |
September 18, 2024 |
U.S. District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on October 2, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel) |
Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel) |
Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Inc. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel) |
Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 9/25/2024, answer due 11/25/2024. (Silver, Daniel) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Remark: The MDL panel has been advised. (mpb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (mpb) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 11,096,918. (mpb) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/6/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/6/2027. (mpb) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
Filing 1 COMPLAINT against Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4501085) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(mpb) Modified on 9/25/2024 (nms). |
No Summons Issued. (mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.